Abstract: It is a feature of a porous body (10, 20) comprising a three-dimensional network of node points (200) joined to one another by struts (100), and a void volume (300) present between the struts (100), that the struts (100) have an average length of ?200 to ?50 mm, the struts (100) have an average thickness of ?100 ?m to ?5 mm, and that the porous body has a compression hardness (40% compression, DIN EN ISO 3386-1: 2010-09) in at least one spatial direction of ?10 to ?100 kPa. The porous body according to the invention combines the advantages of a conventional mattress or cushion with ventilatability which results from its porous structure and is not achievable in conventional foams. The invention further relates to a method of producing such a porous body (10, 20) and to an apparatus comprising said body (10, 20) for supporting and/or bearing a person.

Abstract: A winding assembly for a transformer, in particular with a medium operating voltage of Um?79.5 kV, wherein the winding assembly includes at least one winding, which ends in a winding conductor, where the winding conductor is connected to a switching line, which is configured to interconnect the winding to other windings, and where the connection of the switching line to the winding conductor is arranged inside the winding so as to reduce the danger of partial discharges and flashovers in the high-voltage end-line region for high-temperature applications.

Abstract: A winding assembly for a transformer, in particular with a medium operating voltage of Um?79.5 kV, wherein the winding assembly includes at least one winding, which ends in a winding conductor, where the winding conductor is connected to a switching line, which is configured to interconnect the winding to other windings, and where the connection of the switching line to the winding conductor is arranged inside the winding so as to reduce the danger of partial discharges and flashovers in the high-voltage end-line region for high-temperature applications.

Abstract: A compound of formula (I) wherein R denotes another heterocyclic residue and wherein Ra, Rb, Rc, Rd and Re, are as defined in the specification, processes for their production, their uses, in particular in transplantation, and pharmaceutical compositions containing them.

Abstract: The invention relates to compound of the formula (I), in which the substituents are as defined in the specification; in free form or in salt form; to its preparation, to its use as medicament and to medicaments comprising it.

Abstract: A compound of formula (I), wherein R, R1, R2, ring A, which ring contains one or two nitrogen atoms, and ring B are as defined in the Specification, pharmaceutical compositions containing these compounds, and uses for these compounds and compositions, in particular, in transplantation.

Abstract: A procedure for the identification of a functional disorder of the pancreas by the use of parts of all iso-enzymes of the pancreas elastase and of synthetic amino-acid sequences as antigens for obtaining specific antibodies, as well as their use in immuno-chemical test procedures.

Abstract: A locking mechanism for a wind turbine decelerates and/or locks a rotor or a rotor shaft of the wind turbine. For maintenance work, the rotor or the rotor shaft is lockable to a machine support of the wind turbine in a form-fit manner by utilizing the locking mechanism. A rotational position of the rotor shaft is automatically detected in a DESIRED position. Moreover, the locking mechanism is configured to be automatically engaged when the DESIRED position has been reached. The locking mechanism additionally has at least one deceleration device for affecting the drive train and/or allowing the rotational speed of the rotor and the rotor shaft to be reduced.

Abstract: The invention relates to a method for controlling the start-up phase of a motor vehicle driven by an internal combustion engine (12). The internal combustion engine (12) is started by an electrical machine (16) that can be operated as a motor, and there is a preferably automatically actuatable clutch (50) in the drive train (11) between the internal combustion engine (12) and the electrical machine (16). A faster start-up response can be achieved if the internal combustion engine (12) is driven by the electrical machine (16) when the clutch (50) is engaged during start-up, and if the clutch capacitance (MK) is reduced according to a defined parameter, preferably the engine speed, the time or the torque (ME) of the electrical machine (16) or similar.

Abstract: The invention relates to compound of the formula (I), in which the substituents are as defined in the specification; in free form or in salt form; to its preparation, to its use as medicament and to medicaments comprising it.

Abstract: A compound of formula (I) wherein R denotes another heterocyclic residue and wherein Ra, Rb, Rc, Rd and Re, are as defined in the specification, processes for their production, their uses, in particular in transplantation, and pharmaceutical compositions containing them.

Abstract: The invention relates to compounds of the formula I A-D-C(R1)2—B??(I), in which the substituents are as defined in the specification; in free form or in salt form; to its preparation, to its use as medicament and to medicaments comprising it.

Abstract: A compound of formula (I) wherein R denotes another heterocylic residue and wherein Ra, Rb, Rc, Rd and Re, are as defined in the specification, processes for their production, their uses, in particular in transplantation, and pharmaceutical compositions containing them.

Abstract: A method for controlling the start-up phase of a motor vehicle driven by an internal combustion engine (12) wherein the internal combustion engines (12) is started by an electrical machine (16) that can be operated as a motor, a preferably automatically atuatable clutch (50) being located in the drive train (11) between the internal combustion engine (12) and the electrical machine (16). A faster start-up response can be achieved if the internal combustion engine (12) is driven by the electrical machine (16) when the clutch (50) is engaged during start-up, and if the clutch capacitance (MK) is reduced according to a defined parameter, preferably the engine speed, the time or the torque (ME) of the electrical machine (16) or similar.

Abstract: The present invention pertains “to the use of a PKC inhibitor in the manufacture of a medicament in the treatment or prevention of diabetic complications, where in the PKC inhibitor is one of 3-(1.H.-indol-3-yl)-4-[2-(4-methyl-piperazin-1-yl)-quinazolin-4-yl]-pyrrole-2,5-dione, 3-(1.H.-indol-3-yl)-4-[2-(piperazin-1-yl)-quinazolin-4-yl]-pyrrole-2,5-dione, 3-[3-(4,7-Diaza-spiro [2.5]oct-7-yl)-isoquinolin-1-yl]-4-(7-methyl-1H-indol-3-yl)-pyrrole-2,5-dione or a pharmaceutically acceptable salt thereof.

Abstract: A compound of formula I wherein R, Ra and Rb are as defined in the specification, processes for their production, their uses, in particular in transplantation, and pharmaceutical compositions containing them.

Abstract: Method of performing condensation reactions, acylations or of preparing heterocycles comprising forming cyclic phosphonic anhydride of the formula (III) by a) reacting phosphonic acid derivatives of formula (I) with acetic anhydride at a temperature ranging between 30 and 150° C. while separating a mixture of ethanoic acid and acetic anhydride by means of distillation, b) then reactively distilling the oligomeric phosphonic acid anhydrides of formula (II) obtained in step a) and transforming the same into the corresponding cyclic trimeric phosphonic acid anhydrides of formula (III), wherein n represents a number between 0 and 300 while R represents allyl, aryl, or open-chain, cyclic, or branched C1 to C8 alkyl radicals, aryloxy, allyloxy, or alkoxy comprising open-chain, cyclic, or branched C1 to C8 alkyl radicals. Preferably the cyclic trimeric phosphonic acid anhydrides formed in step b) are immediately dissolved in an organic solvent that exhibits an inert behavior relative thereto.